10
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous Article

Literature Alerts

Pages 119-132 | Published online: 26 Jun 2009

LITERATURE ALERTS

  • 3-(2-Pyridyldithio)propionic acid hydrazide as a crosslinker in the formation of liposome-antibody conjugates. ANSELL, S. M. TARDI, P. G., and BUCHKOWSKY, S. S., Bioconjugate Chem., 1996, 7 (4), 490–496.
  • A quantitative in vivo method of analyzing human tumor-induced angiogenesis in mice using agarose microencapsulation and hemoglobin enzyme-linked immunosorbent assay. OKADA, N., FUSHIMI, M., NAGATA, Y., FUKUNAGA, T., TSUTSUMI, Y., NAKAGAWA, S., and MAYUMI, T., jpn. j. Cancer Res., 1995, 86 (12), 1182–1188.
  • A bacteria-expressed mouse interleukin-1 receptor antagonist peptide protects alginate-poly-L-lysine-alginate microencapsulated rat islets against the suppressive effect of inter-leukin-1 beta in vitro. Hsu, B. R., CHANG, F. H., Fu, S. H., HUANG, Y. Y., JUANG, J. H., and HUANG, H. S., Transplant Proc., 1996, 28 (3), 1961–1963.
  • A method to attach lectins to the surface of spermine/alginate microcapsules based on the avidin biotin interaction. SULTZBAUGH, K. J., and SPEAKER, T.Microencapsulation, 1996,13 (4), 363–376.
  • A month-long effect from a single injection of microencapsulated human growth hormone. JOHNSON, 0. L., CLELAND, J. L., LEE, H. J., CHARNIS, M., DUENAS, E., JAwoRowicz, W., SHEPARD, D., SHIHZANIANI, A., JoNes, A. J. S., and PUTNEY, S. D., Nat. Med. (NY), 1996, 2 (7), 795–799.
  • A new efficient strategy to reconstitute membrane proteins into liposomes: application to the study of Ca"--ATPases. RIGAUD, J. L., and Levy, D., NATO ASI Ser, Ser H, 96 (Molecular Dynamics of Biomembranes), 1996, 383–397.
  • A comparison of carboxylate salts as liposomal cryoprotectants. LLOYD, A. W., OLLIFF, C. J., and RUTT, K. J., Int. y. Pharm., 1996, 131 (2), 257–262.
  • A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy. ZHU, J., ZHANG, L., HANISCH, U. K., FewNER, P. L., and RESZKA, R., Gene Ther., 1996, 3 (6), 472–476.
  • A continuous process for production of ceramic microspheres. ROVERO, G., MONTANARO, L., and NEGRO, A., Mater. Eng. (Modena, Italy), 1995, 6 (4), 335–343.
  • A new liposomal contrast medium for CT of the liver. An imaging study in a rabbit tumor model. LEANDER, P., Acta Radio., 1996, 37 (1), 63–68.
  • A replication-deficient adenovirus enhances liposome-mediated nucleic acid transfer into a stable cell line expressing T7 RNA polymerase. HONDA, M., Hu, P. C., HUANG, C. H., MATSUI, H., and LEMON, S. M.J. Virol. Methods, 1996, 58 (1,2), 41–51.
  • A study on the preparation and stability of APS liposomes. DENG, Y., Liu, S,, HAN, L., MIA°, S., Xu, F., Li, J., Su, D., and Gu, X., Shenyang Yaoke Daxue Xuebao, 1996, 13 (1), 1–4.
  • Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens. GUPTA, R. K., VARANELLI, C. L., GRIFFIN, P., WALLACH, D. F. H., and SIBER, G. R., Vaccine, 1996, 14(3), 219–225.
  • Adsorption of emulsion microsphere to stainless steel surface. FUKUZAKI, S., and NAKANISHI, K., Okayama-ken Kogyo Gijutsu Senta Hokoku, 1995, 21, 11–13.
  • Advanced research on liposome for drug delivery system. KOGURE, K., UENO, M., and TERADA, H., Fragrance .7., 1996, (4), 66–72.
  • Aerosol delivery of interleukin 2 liposomes is nontoxic and biologically effective: Canine studies. KHANNA, C., HASZ, D. E., KLAUSNER, J. S., and ANDERSON, P. M., C/in. Cancer Res., 1996, 2 (4), 721–734.
  • Aerosolization and hygroscopic growth evaluation of lyophilized liposome aerosols under controlled temperature and relative humidity conditions. JOHNSON, D. L., WENGER, E. N., and POLIKANDRITOU, L. M., Aerosol. Sci. Technol., 1996, 25 (1), 22–30.
  • Alcohol binding to liposomes by 2 H NMR and radiolabel binding assays: does partitioning describe binding? DUBEY, A. K., ERYONIIN, V. A., TARASCHI, T. F., and JANES, N., Biophys. 5., 1996, 70 (5), 2307–2315.
  • Alginate polycation microcapsules. I. Interaction between alginate and polycation. Tiqu, B., BRUHEIM, P., ESPEVIK, T., SMIDSROED, 0., SOON, S. P., and SKJAK, B. G., Biomaterials, 1996, 17(10), 1031–1040.
  • Alginate polycation microcapsules. II. Some functional properties. TUG, B., BRUHEINI, P., ESPEVIK, T., SNIIDSROD, 0., SOON, S. P., and SKJAEK, B. G., Biomaterials, 1996, 17 (11), 1069–1079.
  • Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid. ESTEY, E., THALL, P. F., MEHTA, K., ROSENBLUM, M., BREWER, T. JR., SIMMONS, V., CABANILLAS, F., KURZROCK, R., and LOPEZ, B. G., Blood, 1996, 87 (9), 3650–3654.
  • An investigation of the synthesis of poly(DL-lactic acid) and preparation of microspheres containing indomethacin. GOHEL, M. C., PATEL, M. M., KALIL, J. S., PATEL, R. B., PATEL, S. R., and JANt, T. R., Drug Dev. Ind. Pharm., 1996, 22 (7), 637–643.
  • An overview of the latest development of microencapsulation for agricultural products. GIMENO, M., J. Environ. Sci. Health (Part B), 1996, B31 (3), 407–420.
  • Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma. TOKUDOME, Y., OKU, N., Dot, K., NANIBA, Y., and OKADA, S., Biochim. Biophys. Acta, 1996, 1279 (1), 70–74.
  • Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodron-ate and propamidine. VAN ROOIJEN, N., SANDERS, A., and VAN DEN BERG, T. K., J. Immunol. Methods, 1996, 193 (1), 93–99.
  • Application of liposomes in antigen presentation and cytokine delivery. DONG, P., and Ho, J. Y. R., J. Liposome Res., 1996, 6 (2), 305–323.
  • Approaches that mitigate doxorubicin-induced delayed adverse effects on mitochondrial function in rat hearts; liposome-encapsulated doxorubicin or combination therapy with antioxidant. SUGIYANIA, S., YAMADA, K., HAYAKAWA, M., and OZAWA, T., Biochem. Mol. Biol. Int., 1995, 36 (5), 1001–1007.
  • ATP synthesis by the FOF1 ATP synthase from thermophilic Bacillus PS3 reconstituted into liposomes with bacteriorhodopsin. 1. Factors defining the optimal reconstitution of ATP synthases with bacteriorhodopsin. PITARD, B., RICHARD, P., DUNACH, M., GIRAULT, G., and RIGAUD, J. L., Eur. J. Biochem., 1996, 235 (3), 769–778.
  • ATP synthesis by the FOF1 ATP synthase from thermophilic Bacillus PS3 reconstituted into liposomes with bacteriorhodopsin. 2. Relationships between proton motive force and ATP synthesis. PITARD, B., RICHARD, P., DUNACH, M., and RIGAUD, J. L., Eur. J. Biochem., 1996, 235 (3), 779–788.
  • Availability of liposomes as drug carriers to the brain. KOBAYASHI, K., HAN, M., WATARAI, S., and YASUDA, T., Acta Med. Okayama, 1996, 50 (2), 67–72.
  • Basic study on hepatic artery chemoembolization therapy against primary liver cancer using chondroitin sulfate-modified liposomes. NAKANE, Y., FURUSAWA, Y., TAKIZAWA, A., and DENO, M., Drug Delivery Syst., 1996, 11(2), 125–131.
  • Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: influence of PEG content and its molecular weight. VERTUT, D. A., ISHIWATA, H., and MIYAJIMA, K. Biochim. Biophys. Acta, 1996, 1278 (1), 19–28.
  • Bioavailability of meclofenamate from experimental sustained-release microcapsules in beagle dogs. NIAZY, E. M., Int. y. Pharm., 1996, 134 (1,2), 129–135.
  • Bioavailability and stability of microencapsulated ferrous sulfate in fluid milk: studies in mice. Boccio, J. R., ZUBILLAGA, M. B., CARO, R. A., GOTELLI, C. A., GOTELLI, M. J., and WEILL, R., y. Nutr. Sci. Vitaminol., 1996, 42 (3), 233–239.
  • Biological effects of CDP-choline loaded long circulating liposomes on rat cerebral post-ischemic reperfusion. FRESTA, M., and Pucust, G., Int. J. Pharm., 1996, 134 (1,2), 89–97.
  • Candida albicans menigitis in a 27 weeks premature infant treated with liposomal amp-hotericin-B (AmBisome). JARLOV, J. 0., BORN, P., and BRUUN, B., Scand. 1. Infect. Dis., 1995, 27 (4), 419–420.
  • Cardiovascular effects of the microsphere suspending agent, Tween 80, in pigs. GRUND, F., SONINIERSCHILD, H. T., KIRKEBOEN, K. A., and ILEBEKK, A., Acta Physiol. Scand., 1995, 155 (3), 331–332.
  • Change in the N-terminal domain conformation of annexin I that correlates with liposome aggregation is impaired by Ser-27 to Glu mutation that mimics phosphorylation. PORTE, F., DE SANTA BARBARA, P., PHALIPOU, S., LIAUTARD, J. P., and WIDADA, J. S., Biochim. Biophys. Acta, 1996, 1293 (2), 177–184.
  • Changes in charge density and softness of a poly(L-lactide) microcapsule surface in the hydrolytic degradation process. MAKINO, K., and OFISHIMA, H., Colloids Surf., B, 1996, 6 (6), 373–378.
  • Changes in phosphatidylcholine liposomes caused by a mixture of Triton X-100 and sodium dodecyl sulfate. DE LA MAZA, A., and PARRAL, J. L., Biochim. Biophys. Acta, 1996, 1300 (2), 125–134.
  • Characterization of dipalmitoylphosphatidylcholine liposomes containing a soybean-derived steryl glucoside mixture by differential scanning calorimetry, Fourier transform infrared spectroscopy and enzymic assay. Smimizu, K., MAITANI, Y., TAKAYAMA, K., and NAGAI, T.,3. Pharm. Sci., 1996, 83 (7), 741–744.
  • Characterization of dyestuff-containing liposome by capillary zone electrophoresis using online chemiluminescence detection. TSUKAGOSHI, K., AKASAKA, H., NAKAJIMA, R., and HARA, T., Chem. Lett., 1996, (6), 467–468.
  • Chemoembolization of head and neck cancer with carboplatin microcapsules. TOMURA, N., KOBAYASHI, M., HIRANO, J., WATARAI, J., OKAMOTO, Y., TOGAWA, K., KOWADA, M., and MUROTA, H. Acta Radio., 1996, 37 (1). 52–65.
  • Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes. FILIPOVIC, G. J., BECIREVIC, L. M., SKALKO, N., and JALSENJAK, I., Int. y. Pharm., 1996, 135 (1,2), 183–190.
  • Chitosan-drug conjugate microspheres: preparation and drug release properties of micro-spheres composed of the conjugate of 2'- or 3'(4-carboxy-butyry1)-5-fluorouridine with chitosan. ONISH, H., SHIMODA, J., and YOSHIHARU, M., Drug Dev. Ind. Pharm., 1996, 22 (5), 457–463.
  • Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofuratoin. HARI, P. R., CHANDY, HANDY., and SHARMA, C.Microencapsulation, 1996, 13 (3), 319–329.
  • Cholesterol oxidation by microencapsulated cholesterol oxidase. VASUDEVAN, P. T., and ZHOU, T., Appl. Biochem. Biotechnol., 1996, 59 (1), 1–6.
  • Coherent microcapsules for pancreatic islet transplantation: a new approach for bioartfficial pancreas. CALAFIORE, R., BASTA, G., OSTICIOLI, L., LUCA, G., TORTOIOLI, C., and BRUNETTI, P., Transplant Proc., 1996, 28(2), 812–813.
  • Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles. Ramos, H., BRAJTBURG, J., MARQUEZ, V., and COHEN, B. E., Drugs Exp. Clin. Res., 1995, 21(6), 211–215.
  • Competitive immunosorbent assays using ligand-enzyme conjugates and bifunctional lipo-somes: theory and experiment. JONES, M. A., KILPATRICK, P. K., and CARBONELL, R. G., Biotechnol. Prog., 1996, 12 (4), 519–526.
  • Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. VITIELLO, L., CHONN, A., WASSERMAN, J. D., DUFF, C., and WORTON, R. G., Gene Ther., 1996, 3 (5), 396–404.
  • Contribution of process variables to the entrapment efficiency of propranolol hydrochloride within ethyl cellulose microspheres prepared by the solvent evaporation method as evaluated using a factorial design. JONES, D. S., and PEARCE, K. J., Int. y. Pharm., 1996, 131 (1), 25–31.
  • Cotransplantation of microencapsulated hepatocytes and islets for acute hepatic failure in rats. JENG, L. B., Hsu, B. R., Fu, S. H., CHUANG, K. L., LEE, W. C., CHEN, M. F., and CHANG, C. H., Transplant. Proc., 1996, 28 (3), 1859–1860.
  • CTLA4-1g prolongs survival of microencapsulated rabbit islet xenografts in spontaneously diabetic Nod mice. WEBER, C. J., HAGLER, M. K., CHRYSSOCHOOS, J. T., LARSEN, C. P., PEARSON, T. C., JENSEN, P., KAPP, J. A., and LINSLEY, P. S., Transplant Proc., 1996, 28 (2), 821–823.
  • Damage to pBR322 DNA photosensitized by hypocrellin A in liposomes and its derivative in solution. Zou, W., AN, J., and JIANG, L.,.7. Photochem. Photobiol., B, 1996, 33 (1), 73–78.
  • Delivery of DNA-cationic liposome complexes by small-particle aerosol. SCHWARZ, L. A., JOHNSON, J. L., BLACK, M., CHENG, S. H., HOGAN, M. E., and WALDREP, J. C., Hum. Gene Ther., 1996, 7 (6), 731–741.
  • Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. LEE, K. D., OFI, Y. K., PORTNOY, D. A., and SWANSON, J. A., y. Biol. Chem., 1996, 271 (13), 7249–7252.
  • Dermatological applications of liposomes. FATTAL, E., and Puisieux, F., Formes Pharm. Appl. Locale, 1996, pp. 395–411.
  • Development of nifedipine-loaded albumin microspheres using a statistical factorial design. CHUO, W. H., TSAI, T. R., Hsu, S. H., and CHAN], T. M., Int. y. Pharm., 1996, 134(1,2), 247–251.
  • Dexamethasone-loaded magnetic albumin microspheres: preparation and in vitro release. GHASSABIAN, S., EHTEZAZI, T., FORUTAN, S. M., and MORTAZAVI, S. A., /nt. y. Pharm., 1996, 130 (1), 49–55.
  • Different immunosuppressive effects of liposomal FK506 in liver and kidney transplatation. Ko, S., NAKAJIMA, Y., KANEHIRO, H., HORIKAWA, M., YOSHIMURA, A., KIDO, K., TAKI, J., AOMATSU, Y., KIN, T., YAGURAL, K., OHYAMA, T., OHASHI, K., YAMADA, T., and NAKANO, H., Transplant. Proc., 1996, 28 (2), 1066–1068.
  • Differential activation of cell-mediated immune functions by encapsulated and surface-linked liposomal antigens. FORTIN, A., SHAHUM, E., KRZYSTYNIAK, K., and THERIEN, H. M., Cell Immunol., 1996, 169 (2), 208–217.
  • Differential biodistribution of encapsulated and surface-linked liposomal antigens. THERI EN, H. M., and SHAHUM, E., Biochim. Biophys. Acta, 1996, 1280 (1), 91–97.
  • Dispersion polymerization of styrene in polar solvents: effect of reaction parameters on microsphere surface composition and surface properties, size and size distribution, and molecular weight. BAMNOLKER, H., and MARGEL, S., J. Polym. Sci., (Part A: Polym. Chem.), 1996, 34(10), 1857–1871.
  • DOSPER liposomal transfection reagent: a reagent with unique transfection properties. BUCHBERGER, B., FERNHOLZ, E., BANTLE, E., WEIGERT, M., BOROWSKI, E., ELTZ, H., and HINZPETER, M., Biochemica, 1996, (2), 7–10.
  • Drug delivery to the brain using thermosensitive liposome and local hyperthermia. KAKINUMA, K., TANAKA, R., TAKAHASHI, H., SEKIHARA, Y., WATANABE, M., and KUROKI, M., Int. J. Hyperthermia, 1996, 12 (1), 157–165.
  • Drug release from oil-containing microcapsules: I. Mathematical model development. PHARES, K., CHO, M. J., SWARBRICK, J., AMBROSE, W., and JOHNSON, K., mt. J. Pharm. Adv., 1996, 1(4), 357–376.
  • Drug release from oil-containing microcapsules: II. Release data. PHARES, K., CHOL, M., SWARBRICK, J., AMBROSE, W., JOHNSON, K., Int. y. Pharm. Adv., 1996, 1(4), 377–390.
  • Dual microcapsules: preparations and in vitro release rate studies. ERTAN, G., KENDIRCI, A., SARIGULLU, I., and GUNERI, T., Acta Pharm. Turc., 1996, 38 (1), 25–32.
  • Dynamic mechanical properties of polyurethane-urea microcapsules on coated paper. IciIIKAWA, K., Fujifilm Res. Dev., 1996, 41, 117–123.
  • Effect of matrix lipid chain length on liposomes containing cholesterol and ganglioside GM1: Implications in drug delivery. BEDU, A. F. K., and HUANG, L., J. Pharm. Sci., 1996, 85 (7), 714–719.
  • Effect of enzyme microcapsule shape on the performance of a nonisothermal packed-bed tubular reactor. HASSAN, M. M., ATIQULLAII, M., BEG, S. A., and CHOWDHURY, M. H. m., J. Chem. Technol. Biotechnol., 1996, 66 (I), 41–55.
  • Effect of lipophilic antioxidants of peroxidation of liposome membranes photosensitized by hematoporphyrin derivatives upon He-Ne laser irradiation. KLEBANOV, G. I., TesELKIN, Y. 0., BABENKOVA, I. V., ZHANIBALOVA, B. A., VANDANMAGSAR, B., NESTEROVA, 0. A., and STRANADKO, E. F., Biol. Membr., 1996, 13 (2), 133–137.
  • Effect of amphiphilic cationic compounds on calcium ion desorption from lecithin lipo-some membranes. Kinetic studies and quantum chemical calculations. KUCZERA, J., CHOJNACKI, H., KRAL, T. E., and PRZESTALSKI, S., Z. Naturforsch., (C: Biosci.), 1996, 51 (3/4), 219–225.
  • Effect of bilayer additives on encapsulation of steroids in MLV liposomes. KULKARNI, S. B., and VARGHA, B. E. I., Int. y. Pharm. Adv., 1996, 1(4), 408–413.
  • Effect of i.v. injection of small unilamellar liposomes of egg phosphatidylcholine on cholesterol in plasma and erythrocytes, serum enzymes and liver function in dogs. ZON1BER, G., BOGIN, E., and BARENHOLZ, Y., J. Lip osome Res., 1996, 6 (2), 455–477.
  • Effect of liposome encapsulation on immunomodulating and antiviral activities of inter-feron-.gamma. SARAVOLAC, E. G., KOURNIKAKIS, B., GORTON, L., and WONG, J. P., Antiviral Res., 1996, 29 (2,3), 199–207.
  • Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography. OKU, N., TOKUDOME, Y., NAMBA, Y., SAITO, N., ENDO, NI., HASEGAWA, Y., KAWAI, NI., TSUKADA, H., and OKADA, S. Biochim. Biophys. Acta, 1996, 1280 (1), 149–154.
  • Effects of cisplatin loaded biodegradable microspheres in experimental cancer chemo-therapy. MiLis, G., GRANDFILS, C., FLANDROY, P., and BARBASON, H., Pathol. Biol., 1996, 44 (3), 208–211.
  • Effects of liposomes with defined fatty acid composition on xenotransplanted human mammary carcinomas. ZSCFHESCHE, W., NAUNDORF, H., RESZKA, R., SAUL, G. J., and FICHTNER, I., 1996, Cont rib. Oncol., 51 (Immunodeficient Animals: Models for Cancer Research), 138–141.
  • Effects of molecular weight of PVA on the adsorption and dispersibility of silica microspheres in aqueous media. HORINOUCHI, K., KOMARKI, H., and SENNA, M., Nihon. Reoroji. Gakkaishi, 1996, 24 (1), 21–27.
  • Effects of phospholipid composition on adjuvant efficiency of liposomes. HAMPL, J., FRANZ, J., JORDANOVA, K., and STEPANEK, J., Acta Vet. Brno., 1995, 64 (2), 163–169.
  • Effects of aluminum adjuvant compounds, Tweens, and Spans on the stability of liposome permeability. IVIUDERHWA, J. M., WASSEF, N. M., SPITLER, L. E., and ALVING, C. R., Vaccine Res., 1996, 5 (1), 1–13.
  • Effects of COR6.6 and COR15am polypeptides encoded by COR (cold-regulated) genes of Arabidopsis thaliana on the freeze-induced fusion and leakage of liposomes. UEMURA, NI., GILMOUR, S. J., THOMASHOW, NI. F., and STEPONKUS, P. L., Plant Physiol., 1996, 111 (I), 313–327.
  • Effects of delayed treatment with nafronyl oxalate on microsphere embolism-induced changes in monoamine levels of rat brain regions. TAKAGI, N., MIYAKE, K., OHINVA, A., NUKAGA, R., and TAKEO, S., Br. y. Pharmacol., 1996, 118 (1), 33–40.
  • Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes. HARA, T., KUWASAWA, H., ARAMAKI, Y., TAKADA, S., KOIKE, K., ISHIDATE, K., KATO, H., and TSUCHIYA, S., Biochim. Biophys. Acta, 1996, 1278 (1), 51–58.
  • Effects of polyethylene glycol chain length and phospholipid acyl chain composition on the interaction of polyethylene glycol-phospholipid conjugates with phospholipid: implica-tions in liposomal drug delivery. BEDU, A. F. K., TANG, P., Xu, Y., and HUANG, L., Pharm. Res., 1996, 13 (5), 710–717.
  • Effects of liposome composition on erythromycin encapsulation and in vitro antibacterial activity. PANICO, A., PIGNATELLO, R., PUGLISI, G., FURNERI, P. M., CAMPO, L., CERNIGLIA, G., CASTELLI, F., and MAZZONE, P., Int. y. Pharm. Adv., 1996, 1 (4), 443–458.
  • Effects of liposome size on penetration of dl-tocopherol acetate into skin. NATSUKI, R., MORITA, Y., ()SAWA, S., and TAKEDA, Y., Biol. Pharm. Bull., 1996, 19 (5), 758–761.
  • Effiacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group. GOEBEL, F. D., GOLDSTEIN, D., Goos, M., JABLONOWSKI, H., and STEWART, J. S., Br. y. Cancer, 1996, 73 (8), 989–994.
  • Efficacy of microencapsulation of a pancreatic B-cell line (MIN6) in an agarose/PSSa microbead as a bioartificial pancreas. WANG, W. J., INoue, K., HAYASHI, H., AUNG, T., TUN, T., Gu, Y. J., KAJI, H., ECHIGO, Y., KATO, M., Doi, R., SETOYAMA, H., KAWAKAMI, Y., IMAMURA, M., MAETANI, S., MORIKAWA, N., IWATA, H., IKADA, Y., and MIYAZAKI, J. I., Transplant. Proc., 1996, 28 (2), 1094–1096.
  • Efficient transfer of regulated genes in adipocytes and hepatoma cells by the combination of liposomes and replication-deficient adenovirus. MEUNIER, D. C., FERRY, N., HAINQUE, B., DELAT-ras, J., and FOREST, C., Eur. y. Biochem., 1996, 237 (3), 660–667.
  • Embryotoxicity and teratogenicity studies of poly (DL-lactide-co-glycolide) microspheres incorporated tetanus toxoid in Wistar rats. CHANDRASEKAFtAN, R., GIRT, D. K., and CHAUDHURY, M. R., Hum. Exp. Toxicol., 1996, 15 (4), 349–351.
  • Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. FRIEND, D. S., PAPAHADJOPOULOS, D., and DEBS, R. J., Biochim. Biophys. Acta, 1996, 1278 (1), 41–50.
  • Enhanced antitumor effect of radiation in combination with heat-sensitive liposome-encapsulated drug and hyperthermia on murine tumors. TAMIZ, C. P., and RANJU, R., 5. Clin. Biochem. Nutr., 1995, 19 (3), 137–146.
  • Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. TAKEUCHI, H., YAMAMOTO, H., NIWA, T., HINO, T., and KAWASHIMA, Y Pharm. Res., 1996, 13(6), 896-901. Enzyme-containing liposomes can endogenously produce membrane-constituting lipids. WICK, ICK., and Luis', P. L., Chem. Biol., 1996, 3 (4), 277–285.
  • Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres. XING, D. K. L., MCLELLAN, K., CORBEL, M. J., and SESARDIC, D., Biologicals, 1996, 24 (1), 57–65.
  • Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer. EGLIMEZ, N. K., IWANUMA, Y., and BANKERT, R. B., Biochem. Biophys. Res. Commun., 1996, 221 (1), 169–173.
  • Evaluation of in vitro stability of large unilamellar liposomes coated with a modified polysaccharide (0-palmitoylpullulan). MOREIRA, J. N., ALMEIDA, L. M., GERALDES, C. F., and COSTA, M. L., .7. Mater. Sci. Mater. Med., 1996, 7 (5), 301–303.
  • Evaluation of liposomal formulations containing the antimalarial agent, arteether. AL ANGARY, A. A., AL MESHAL, M. A., BAYOMI, M. A., and KHIDR, S. H., Int. y. Pharm., 1996, 128 (1,2), 163–168.
  • Evaluation of ketoprofen liposomes for the antiarthritic activity. KHANDARE, J. N., DALMIA, R., and MANCHANDA, R., Indian Drugs, 1996, 33 (2), 63–66.
  • Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection. YANAGIHARA, I., INUI, K., DICKSON, G., TURNER, G., PIPER, T., KANEDA, Y., and OKADA, S., Gene Ther., 1996, 3 (6), 549–553.
  • Extraction of Pd(II) using microcapsule with consequent elutriation. BAI, G., WANG, Y., Li, Y., and ZHANG, H., Huaxue Yanjiu Yu Yingyong, 1995, 7 (2), 158–161.
  • Factors influencing release of salbutamol sulfate from poly(lactide-co-gycolide) micro-spheres prepared by water-in-oil-in-water emulsion technique. ERDEN, N., and CELEBI, N., Int. y. Pharm., 1996, 137 (1), 57–66.
  • Fate of cationic liposomes and their complex with oligonucleotide in vivo. LITZINGER, D. C., BROWN, J. M., WALA, I., KAUFMAN, S. A., VAN GWYNETH, Y., FARRELL, C. L., and COLLINS, D., Biochim. Biophys. Acta., 1996, 1281 (2), 139–149.
  • Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue. FORSSEN, E. A., MALE, B. R., ADLER, M. J. P., LEE, M. J., SCHMIDT, P. G., KRASIEVA, T. B., SHIMIZU, S., and TROMBERG, B. J., Cancer Res., 1996, 56 (9), 2066–2075.
  • Fluorescence polarization study on the dynamics and location of peroxidized fluorescent phospholipids in liposomes. WANG, J. Y ., SUZUKI, K., MIYAZAWA, T., UEKI, T., and KOUYAMA, T., Arch. Biochem. Biophys., 1996, 330 (2), 387–394.
  • Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. LEE, R. J., and HUANG, L., y. Biol. Chem., 1996, 271 (14), 8481–8487.
  • Free radicals from 1-palmitoy1-2-arachidonoylphosphatidylcholine liposomes in Fe2+/ ascorbic acid solution. YOSHIDA, T., OTAKE, H., ARANIAKI, Y., HARA, T., TSUCHIYA, S.; HAmium, A., and DTSUMI, H., Biol. Pharm. Bull., 1996, 19 (6), 779–782.
  • Fundamental studies of targeting chemotherapy with cisplatin encapsulated liposome. KOKETSU, M., Nagoya-shiritsu Daigaku Igakkai Zasshi, 1996, 47 (2), 139–154.
  • Gamma-irradiation of liposomes composed of saturated phospholipids: effect of bilayer composition, size, concentration and absorbed dose on chemical degradation and physical destabilization of liposomes. ZUIDAM, N. J., VeasLum, C., VERNOOY, E. A., and CRONIMELIN, D. J., Biochim. Biophys. Acta, 1996, 1280 (1), 135–148.
  • Gene transfer to the retina of rat by liposome eye drops. MATSU°, T., MASUDA, I., YASUDA, T., and MATSU°, N., Biochem. Biophys. Res. Commun., 1996, 219 (3), 947–509.
  • High strain rate and other properties of a carbon microsphere reinforced magnesium alloy. HALL, I. W., and PoTEET, C., y. Mater. Sci. Lett., 1996, 15 (12), 1015–1017.
  • High-performance liquid chromatography of peptides on a microspherical carbon column. YAMAKI, S., ISOBE, T., OKUYAMA, T., and SHINODA, T., y. Chromatogr., (A), 1996, 729 (1,2), 143–153.
  • Hollow lead zirconate titanate microspheres prepared by sol-gel/emulsion technique. YANG, X., and CHAKI, T. K., Mater. Sci. Eng., (B), 1996, B39 (2), 123–128.
  • Human skin irritation studies of a lecithin microemulsion gel and of lecithin liposomes. DREHER, F., WALDE, P., Luim, P. L., and ELSNER, R., Skin Pharmacol., 1996, 9 (2), 124–129.
  • Hypochlorite-induced peroxidation of phospholipid liposomes. A comparison with peroxida-tion in the Fe"Vascorbate system. PANASENKO, 0. M., ARNKHOL, D. Y., ARNOL, D. K., VLADIMIROV, Y. A., and SERGIENKO, V. I., Biofizika, 1996, 41(2), 334–341.
  • Immobilization of enzymes and living cells by multilayer microcapsules. VOGT; W., BACHEN, M., GAUMANN, A., JAcoe, B., LAUE, C., POMMERSHEIM, R., and ScnaczENmEnt, J., DECHEMA Monogr, 1996, 132, 195–204.
  • Immune lysis assay of antibodies by use of antigen-coupled liposomes. KATOH, S., KISHIMURA, M., and TomwicA, K., Colloids Surf., A, 1996, 109, 195–200.
  • Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomes. BOECKLER, C., FRISCH, B., MULLER, S., and SCHUBER, F., . y. Immunol. Methods, 1996, 191 (1), 1–10.
  • Improved antitumor activity of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexan-eplatinum (II) entrapped in long-circulating liposomes. Li, S., KHOKHAR, A. R., PERE; S. R., and HUANG, L., Oncol. Res., 1995, 7 (12), 611–617.
  • Improvement of intraperitoneal chemotherapy for rat ovarian cancer using cisplatin-containing microspheres. KUMAGAI, S., SUGIYAMA, T., NISHIDA, T., DSHIJIMA, K., and YAKUSHIJI, M., jpn. .7. Cancer Res., 1996, 87 (4), 412–417.
  • In situ activation of mouse alveolar macrophages by aerosolized liposomal IFN-gamma and muratnyl tripeptide. GOLDBACH, P., DUMONT, S., KESSLER, R., POINDRON, P., and STAMM, A., Am. y. Physiol., 1996, 270 (3 Pt 1), L429–L434.
  • In vitro and in vivo evaluation of PLAGA (50/50) microspheres containing 5-fluorouracil prepared by a solvent evaporation method. CIFTCI, K., KAs, H. S., HINCAL, A. A., ERCAN, T. M., GUEVEN, 0., and RUACAN, S., Int. y. Pharm., 1996, 131 (1), 73–82.
  • In vitro and in vivo evaluation of chitosan microspheres of anti-inflammatory drugs. VURAL, I., Acnwoz, M., KAS, H. S., ERCAN, M. T., HASCELIK, Z., and HINCAL, A. A., Chitin World, (Proc. Int. Conf. Chitin Chitosan), 1994, pp. 562–574.
  • In vitro and in vivo gene transfer to pulmonary cells mediated by cationic liposomes. FORTUNATI, E., BOUNT, A., ZANTA, M. A., VALERIO, D., and SCARPA, M., Biochim. Biophys. Acta, 1996, 1306 (1), 55–62.
  • In vitro and in vivo evaluation of polylactide and polylactide-co-glycolide microspheres of morphine for site-specific delivery. POLARD, E., LE CORRE, P., CHEVANNE, F., and LE VERGE, R., Int. y. Pharm., 1996, 134 (1,2), 37–46.
  • In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells. AKSENTIJEVICH, I., PASTAN, I., LUNARDI, I. Y., GALLO, R. C., GoTTEsmAN, M. M., and THIERRY, A. R., Hum. Gene. Ther., 1996, 7 (9), 1111–1122.
  • In vitro retinoic acid release and skin permeation from different liposome formulations. MONTENEGRO; L., PANIC°, A. M., VENTIMIGLIA, A., and BONINA, F. P., lat. y. Pharm., 1996, 133 (1,2), 89–96.
  • In vivo studies of amylose- and ethyl cellulose-coated (13C)glucose microspheres as a model for drug delivery to the colon. CUMMINGS, J. H., MILOJEVIC, S., HARDING, M., COWARD, W. A., GIBSON, G. R., BOTHAM, R. L., RING, S. G., WRAIGHT, E. P., STOCKHAM, M. A., et al. y. Controlled Release, 1996, 40 (1-2), 123–131.
  • In vivo gene transfer of insulin gene into neonatal rats by the HVJ-liposome method resulted in sustained transgene expression. TOMITA, N., MORISHITA, R., HIGAKI, J., TOMITA, S., AOKI, M., OGIHARA, T., and KANEDA, Y., Gene They., 1996, 3 (6), 477–482.
  • In vitro antifungal activity of liposome-encapsulated griseofulvin. Ezz EL D. M. M., ABU ZAID, S. S., and GHANEM, E. H., Air. J. Myco. Biotechnol., 1995, 3 (2), 89–99.
  • In vitro synthesis of an N-myristoylated fusion protein that binds to the liposomal surface. UTSUMI, T., KURANANII, J., Tou, E., IDE, A., AKIMARU, K., HUNG, NI. C., and KLOSTERGAARD, J., Arch. Biochem. Biophys, 1996, 326 (2), 179–184.
  • In-vivo studies on dexamethasone sodium phosphate liposomes. AL MUHAMMED, J., OZER, A. Y., ERCAN, M. T., and HINCAL, A. A., J. Microencapsulation, 1996, 13 (3), 293–305.
  • Increased liposome extravasation in selected tissues: effect of substance P. ROSENECKER, J., ZHANG, W., HONG, K., LAUSIER, J., G., PIERANGELO, YOSHIHARA, S., PAPAHAD3OPOULOS, D., and NADEL, J. A., Proc. Natl. Acad. Sci. USA, 1996, 93 (14), 7236–7241.
  • Increasing hepatic arterial flow to hypovascular hepatic tumours using degradable starch microspheres. CHANG, D., JENKINS, S. A., GRIME, S. J., NOTT, D. M., and COOKE, T., Br. y. Cancer, 1996, 73 (8), 961–965.
  • Indomethacin-loaded chitosan microspheres. Correlation between the erosion process and release kinetics. ORIENT', I., AIEDEH, K., GIANASI, E., BERTASI, V., and ZECCHI, V., J. Microencapsulation, 1996, 13 (4), 463–472.
  • Influence of the preparation method on residual solvents in biodegradable microspheres. BITZ, C., and DOELKER, E., Int. y. Pharm., 1996, 131 (2), 171–181.
  • Influence of cholesterol on the association of plasma proteins with liposomes. SEMPLE, S. C., CHONN, A., and CuLLis, P. R., Biochemistry, 1996, 35 (8), 2521–2525.
  • Influence of dose on liposome clearance: critical role of blood proteins. OJIA, C. D., SEMPLE, S. C., CHONN, A., and Cum.'s, P. R., Biochim. Biophys. Acta, 1996, 1281 (1), 31–37.
  • Influence of the casting solvent on the physico-chemical properties of 5-fluorouracil loaded microspheres. ZINUTTI, C., KEDZIEREWICZ, F., HOFFMAN, M., BENOIT, J. P., and MAINCENT, P., Int. y. Pharm., 1996, 133 (1,2), 97–105.
  • Inorganic microcapsules for controlled release systems. NAKAHARA, Y., Adv. Sci. Technol., 1995, 10 (Intelligent Materials and Systems), 239–250.
  • Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. USTER, P. S., ALLEN, T. M., DANIEL, B. E., NIENDez, C. J., NEWMAN, M. S., and ZHU, G. Z., FEBS-Lett., 1996, 386 (2-3), 243–246.
  • Interaction of polyethylene glycol-phospholipid conjugates with cholesterol-phosphatidyl-choline mixtures: sterically stabilized liposome formulations. BEDU ADDO, F. K., TANG, P., Xu, Y., and HUANG, L., Pharm. Res., 1996, 13 (5), 718–724.
  • Interaction of human immunodeficiency virus type 1 envelope protein with liposomes containing galactosylceramide. BERSON, J. F., Doms, R. W., LONG, D., Perspect. Drug Discovery Des., 1996, 5 (HIV Infection in CD4-Cells), 169–180.
  • Interaction of phospholipid liposomes with plasma membrane isolated from alveolar type II cells: effect of pulmonary surfactant protein A. KUROKI, Y., SHIRATORI, M., OGASAWARA, Y., HAT-reoi, A., TSUNEZAWA, W., HONMA, T., and AKINO, T., Biochim. Biophys. Acta, 1996, 1281 (1), 53–59.
  • Interaction of recombinant human bone morphogenetic protein-2 with poly(DL-lactide-co-glycolide) microspheres. DUGGIRALA, S. S., MEHTA, R. C., and DELucA, P. P., Pharm. Dev. Technol., 1996, 1(1), 11–19.
  • Interaction of cationic liposomes with skin bacteria. SANDERSON, N. M., and JONES, M. N., Biochem. Soc. Trans., 1995, 23 (4), 561S.
  • Interaction of equimolecular mixtures of nonionic/anionic surfactants with liposomes. DE LA MAZA, A., and PARRA, J. L., Langmuir, 1996, 12 (14), 3393–3398.
  • Interaction of surfactants with model and biological membranes. XXII. Spectrophotometric estimation of the partition coefficient of the local anesthetic heptacaine between phospholipid liposomes and aqueous phase. HAMMEL, M., UHRIKOVA, D., and BALGAVY, P., Ceska Slay. Farm., 1996, 45 (2), 58–66.
  • Interleukin-2 as a co-adjuvant for liposomal tetanus toxoid. GURSEL, NI., and GREGORIADIS, G., NATO AS Ser, Ser. A., 282 (Vaccines: New Generation Immunological Adjuvants), 1995, 45–50.
  • Intermediate aggregates resulting in the interaction of sodium dodecyl sulfate with phos-phatidylcholine liposomes. DE LA MAZA, A., and PARRA, J. L., Colloids Surf, A, 1996, 112 (1), 63–71.
  • Intratumor administration of fusogenic liposomes containing fragment A of diphtheria toxin suppresses tumor growth. MIZUGUCHI, H., NAKANISH, T., NAKANISHI, NI., NAKAGAWA, T., NAKAGAWA, S., and MAYUMI, T., Cancer Lett., 1996, 100 (1-2), 63–69.
  • Ionizing radiation induced changes in the functional properties of sarcoplasmic re-ticulum Caz+-ATPase from rabbit skeletal muscles reconstructed into liposomes. HIZFINYAK, S. V., VOITSKITSKY, V. NI., and KUNCHERENKO, N. E., Biol. Membr., 1996, 13 (2), 208–215.
  • Is control of distribution of liposomes between tumors and bone marrow possible? NAGAYASU, A., UCHIYAMA, K., NISHIDA, T., YAMAGIWA, Y., KAWAI, Y., and KIWADA, H., Biochim. Biophys. Acta, 1996, 1278 (1), 29–34.
  • Kinetic studies on cytosine arabinoside permeation through the egg phosphatidylcho-line liposomal membrane. FUKUOKA, N., TSUKAMOTO, T., NAKANO, M., SHIBATA, A., and YAMASHITA, T., Chem. Pharm. Bull., 1996, 44(5), 1124–1127.
  • Kupffer cell depletion by liposome-delivered drugs: Comparative activity of intracellular clodronate propamidine, and ethylenediaminetetraacetic acid. VAN ROOIJEN, N., and SANDERS, A., Hepatology (Philadelphia), 1996, 23 (5), 1239–1243.
  • Laser oscillation characteristics of the glass microsphere. MamA, K., and HIRAO, K., Opt Tonics, 1996, 173, 157–163.
  • Light scattering properties and crystallization in microspheres of novel rewritable recording materials of fatty acid/polymer films. TSUTSUI, K., and SATO, K., Kotai Butsuri, 1996, 31 (5), 500–506.
  • Lipid peroxidation in egg phosphatidylcholine liposomes: comparative studies on the induction systems Fe2*/ascorbate and Fe3+-chelates/xanthine-xanthine oxidase. FUKUZAWA, K., LEMURA, M., and TOKUMURA, A., Biol. Pharm. Bull., 1996, 19(5), 665–671.
  • Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy. MEHTA, S. C., LA, J. C. K., and Lu, D. R., Y. Micro-encapsulation, 1996, 13 (3), 269–279.
  • Liposomal Arg-Gly-Asp analogs effectively inhibit metastatic B16 melanoma colonization in mI unne .ungs. Oxu, N., TOKUDOME, Y., KOIKE, C., NISHIKAWA, N., Moat, H., SAIKI, I., and OKADA, S., Life-Sci., 1996, 58 (24), 2263–2270.
  • Liposomal DNA vectors for cystic fibrosis gene therapy. Current applications, limitations, and future directions. SCHREIER, H., and SAWYER, S. M., Adv. Drug Delivery Rev., 1996, 19 (1), 73–87.
  • Liposomal and lipid-based formulations of amphotericin B. DE MARIE, S., Leukemia, 1996, 10 (Suppl 2), s93-s96, 34 (Refs).
  • Liposomal targeting and drug delivery: kinetic consideration. HARASHINIA, H., and KIWADA, H., Adv. Drug Delivery Rev., 1996, 19 (3), 425–444.
  • Liposomal vaccines. GREEN, S., FORTIER, A., DIJKSTRA, J., MADSEN, J., SWARTZ, G., EINCK, L., GUBISFI, E., and NAGY, C., Adv. Exp. Med. Biol., 1995, 383, 83–92. 27 (Refs).
  • Liposome drug delivery system for progressive neuroblastoma. NAGAE, I., and Pro, S., Tokyo Ika Daigaku Zzsshi, 1996, 54(1), 24–35.
  • Liposome mediated immunopotentiation and immunomodulation. VAN ROOIJEN, N., NATO AS Ser, (Ser A), 1995, 282 (Vaccines: New Generation Immunological Adjuvants), 15–24.
  • Liposome-based cancer vaccines. BERGERS, J. J., OTTER, W. DEN., and CROMNIELIN, D. J. A.J. Liposome Res., 1996, 6 (2), 339–355.
  • Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumors after intravenous administration. LOVE, W. G., Dug, S., BIOLO, R., Jost, G., and TAYLOR, P. W., Photochem. Photobiol., 1996, 63 (5), 656–661.
  • Liposome-mediated NGF gene transfection increases ChAT activity in CNS cell cultures. LE, W., YANG, K., WHITSON, J. S., CLIFTON, G. L., and HAVES, R. L., Neuro Report, 1996, 7 (3); 710–712.
  • Liposome-medicated gene transfer and expression via the skin. ALEXANDER, M. Y., and AKHURST, R. J., Hum. Mol. Genet., 1995, 4 (12), 2279–2285.
  • Liposomes in cosmetics and skin care. SOOD, A., VENUGOPLAN, P., VENKATESAN, N., and VYAS, S. P., Indian Drugs, 1996, 33 (2), 43–49.
  • Liposomes in pharmacists laboratory. HERZOG, R., Dtsch. Apoth. Ztg., 1996, 136 (12), 29–32.
  • Liposomes induce potent humoral responses to T-independent antigens. GARCON, N., and FRIEDE, M.,.7. Liposome Res., 1996, 6 (2), 381–395.
  • Liposomes. LASIC, D. D., Sci. Med. (Philadelphia) 1996, 3 (3), 34–43.
  • Liposomes: presentation and applications in medicine. BEJAN, A., and TuRcu, G., Rev. Roum. Med. Interne., 1995, 33 (3–4), 141–149.
  • Liquid-liquid emulsification by static mixers for use in microencapsulation. MAA, Y. F., and Hsu, C., y. Microencapsulation, 1996, 13 (4), 419–433.
  • Long-term expression of the human alpha 1-antitrypsin gene in mice employing anionic and cationic liposome vectors. CRESPO, J., BLAYA, C., CRESPO, A., and ALINO, S. F., Biochem. Pharmacol., 1996, 51 (10), 1309–1314.
  • Lowering of threshold conditions for nonlinear effects in a microsphere. BRAUNSTEIN, D., KHAZANOV, A. M., KOGANOV, G. A., and SHUKER, R., Phys. Rev. A: At, Mol., Opt. Phys., 1996, 53 (5), 3565–3572.
  • Macrophage activation by liposomal lipid A: implications for vaccines. GLENN, G. M., and ALVING, C., y. Liposome Res., 1996, 6 (2), 325–338.
  • Macrophage activation by liposomal lipid A: implications for vaccines. GLENN, G. M., and ALVING, C., J. Liposome Res., 1996, 6 (2), 325–338.
  • Macrophage-mediated tumor cytotoxicity of alkylphosphocholine liposomes. &ism, R., JUNGMANN, S., EUE, 1., DAEMEN, T., FICHTNER, 1., NISSEN, E., and ARNDT, D., Phospholipids: Charact., Metab., Novel Biol. Appl., Proc., Int., Colloq., 6th, AOCS Press, Champaign, III, 1995, pp. 126–133.
  • Measurement of ocular circulation using colored microsphere technique. TAMAKI, Y., ARAIE, M., TONIIDOKORO, A., and TONIITA, K. Atarashii Ganka, 1996, 13 (3), 403–406.
  • Measurement of mouse anti-phospholipid antibodies to solid-phase microspheres by both flow cytofluorometry and Alcian blue-pretreated microtitre plates in an ELISA. LAAKE, M., BOUCHARD, M., and LAGACE, J., J. Immunol. Methods, 1996, 190 (2), 267–273.
  • Mechanism of DNA release from cationic liposome/DNA complexes used in cell trans-fection. Xu, Y., and SZOKA, F. C. JR., Biochemistry, 1996, 35 (18), 5616–5623.
  • Melt crystallization of behenic acid in microspheres dispersed in polymer. TSUTSUI, K., HorrA, Y., and SATO, K., y. Cryst. Growth, 1996, 163 (4), 440–444.
  • Membrane-damaging action of Colstridium perfringens alpha-toxin on phospholipid lipo-somes. NAGAHAMA, M., MICHIUE, K., and SAKURAI, J., Biochim. Biophys. Acta, 1996, 1280 (1), 120–126.
  • Micro cross-sectioning and quantitative estimation of internal vacancy of inorganic micro-capsules by gallium focused ion beam SIMS. TOMIYASU, B., OWARI, M., and NIHEI, Y., Second Ion Mass. Spectrom, Proc. Int. Conf., 9th, Wiley, 1994, pp. 565-568. Microcapsules. ISHII, K., Techno. Cosmos, 1996, 9, 40–46.
  • Microencapsulated ciliary neurotrophic factor: Physical properties and biological activities. IVIAysiNcER, D., KRIEGLSTEIN, K., FILIPOVIC, G. J., SENDTNER, M., UNSICKER, K., and RICFIARDSON, P., Exp. Neurol., 1996, 138 (2), 177–188.
  • Microencapsulated phase-change material suspensions for heat transfer in spacecraft thermal systems. MULLIGAN, J. C., COLVIN, D. P., and BRYANT, Y. G., Y. Spacecr. Rockets, 1996, 33 (2), 278–284.
  • Microencapsulation of a virucide agent by evaporation of the solvent and interfacial polymerization. BRUJES, L., MORANCAIS, P., CARNELLE, G., LEGRAND, J., CHEYNIOL, A., and PHALIP, P., Recents Prog Genie Procedes, 1995, 8 (39, Strategie dAcces au Produit Industriel), 19–24.
  • Microencapsulation of living cells. GoosEN, M. F. A., Immobilised Living Cell. Syst., Wiley, Chichester, UK, 1996, pp. 295–322.
  • Microencapsulation of pepper oleoresin by using spray drying. SUDIBYO, A., DJUBAEDAH, E., and SUPRAPTO, N., Warta IHP, 1995, 12 (1-2), 85–90.
  • Microencapsulation of recombinant Saccharomyces cerevisiae cells with invertase activity in liquid-core alginate capsules. CHANG, H. N., SEONG, G. H., Yoo, I. K., PARK, J. K., and SEO, J. H., Biotechnol Bioeng, 1996, 51(2), 157–162.
  • Microsphere synthesis by emulsion copolymerization of methyl methacrylate with binary macromonomer blends. Isinzu, K., and TAHARA, N., Polymer, 1996, 37 (9), 1729–1734.
  • Microsphere synthesis by emulsion copolymerization of methyl methacrylate with poly (methacrylic acid) macromonomers. ISHIZU, K., and TAHARA, N., Polymer, 1996, 37 (13), 2853–2856.
  • Microspheres based detoxification system: a new method in convective blood purification. APPEN, K. VON., WEBER, C., LOSERT, U., SCHIMA, H., GURLAND, H. J., and FALKENHAGEN, D., Artif Organs, 1996, 20 (5), 420–425.
  • Microspherical phenolic resin bonding agent prepared by suspension method (PTS) and its application. Li, Y., jingangshi Yu Moliao Moju Gongcheng, 1995, 27 (6), 23–24.
  • Model ligands linked to polymer chains on liposomal surfaces: application of a new functionalized polyethylene glycol-lipid conjugate. ZALIPSKY, S., NEWNIAN, M. S., PUNATAMBEKAR, B., and WOODLE, M. C., Polym. Mater. Sci. Eng., 1993, 69, 519–520.
  • Modification and functionalization of hydrogel microspheres. KAWAGUCHI, H., FUJINIOTO, K., NAKAZAWA, Y., SAKAGAWA, M., ARIYOSHI, Y., SHIDARA, M., OKAZAKI, H., and FBISAWA, Y., Colloids Surf, A, 1996, 109, 147–154.
  • Modified polystyrene microspheres for dextran adsorption. Application in protein chro-matography. FOURNIER, C., LEONARD, M., and DELLACHERIE, E., Recents Prog. Genie. Procedes, 1996, 10 (46, Nlicrophenomenes aux Microtechnologies), 87–92.
  • Multilamellar multivesicular liposomes. Methodology, and cosmetic application. GARCIA, A. J. M., NIETO, A., NIARTI, E., DEL Pozo, A., DELGADO, R., PONS, F., and PARENTE, A., Cosmet. News, 1996, 19 (106), 32–36.
  • Nifedipine and nifedipine-cyclodextrin complexes in liposomes and microspheres. SKALKO, N., FILIPOVIC, G. J., 13Eciazylc, L. M., and JALSENJAK, I., Acta Pharm. (Zagreb), 1996, 46 (2), 159–168.
  • Nitric oxide inhibits peroxynitrite-induced production of hydroxyeicosatetraenoic acids and Non-phospholipid liposomes: a novel method for the preparation of hemoglobin containing lipid vesicles. ROHLFS, R. J., and VANDEGRIFT, K. F., Blood Substitutes: New Challenges, Birkhaeuser, Boston, Mass, 1996, pp. 163–184.
  • Non-phospholipid fusogenic liposomes. EL BARAKA, M., PECHEUR, E. I., WALLACH, D. F., and PHILIPPOT, J. R., Biochim. Biophys. Acta, 1996, 1280 (1), 107–114.
  • Novel homogeneous liposomal immunoassay for colorimetric estimation of serum IgG anticardiolipin antibodies. FROST, S. J., CHAKRABowrY, J., and FIRTH, G. B., Clin. Chem. (Washington, DC), 1996, 42 (6, Pt. 1), 874–879.
  • Novel technology for the preparation of sterile alginate-poly(L-lysine) microcapsules in a bioreactor. ABRAHAM, S. M., VIETH, R. F., and BURGESS, D. J., Pharm. Dev. Technol., 1996, 1 (1), 63–68.
  • Novel method to form giant liposome entrapping DNA. KUMAZAWA, N., NIEL NiKov A, Y. S., and YOSHIKAWA, K., Marromo/. Symp., 1996, 106 (Nano-Structures and Self-Assemblies in Polymer Systems), 219–223.
  • On the producing process and apparatuses for the hollow glass microspheres. KIMURA, K., and OKADA, H., Kyushu Kogyo Gijutsu Kenkyusho Hokoku, 1996, 56, 3507–3514.
  • Optimization of 7-day release (in vitro) from DL-PLA methadone microspheres. DELGADO, A., EvoRA, C., and LLABRES, M., Int. y. Pharm., 1996, 134 (1,2), 203–211.
  • Optimization of microencapsulating and compacting conditions for hydrogen storage alloy. AKIYAMA, T., TAZAKI, T., TAKAHASHI, R., and YAGI, J., J. Alloys. Compd., 1996, 236,171-176. Oral vaccination with alginate microsphere systems. BOWERSOCK, T. L., HOGENESCH, H., SUCKOW, UCKOW., PORTER, R. E., JACKSON, R., PARK, H., and PARK, K.,Controlled Release, 1996,39 (2,3), 209–220.
  • Organic solvent-free polymeric microspheres prepared from aqueous colloidal polymer dispersions by a w/o-emulsion technique. CHAt4o, C. M., and BODME1ER, R., Int. y. Pharm., 1996, 130 (2), 187–194.
  • Ovalbumin-liposome conjugate induces IgG but not IgE antibody production. NAITO, S., HORINO, A., NAKAYAMA, M., NAKANO, Y., NAGAI, T., MIZUGUCHI, J., KOMURO, K., and UCHIDA, T., Int. Arch. Allergy. Immunol., 1996, 109 (3), 223–228.
  • Peptide attachment to extremities of liposomal surface grafted PEG chains: preparation of the long-circulating form of laminin pentapeptide, YIGSR. ZALIPSKY, S., PUNTAMBEKAR, B., BOULIKAS, P., ENGBERS, C. M., and WOODLE, M. C., Biocongug. Chem., 1995, 6 (6), 705–708.
  • Peptide-coupled liposomes for homogeneous immunoassay of polyclonal antibodies against proteins. TONIIOKA, K., OKADA, W., FUKUDA, H., and KATOH, S., Chem. Eng. y. (Lausanne), 1996, 62 (3), 169–174.
  • Percutaneous intratumoral injection of cisplatin microspheres in tumor-bearing rats to diminish acute nephrotoxicity. KUANG, L., YANG, D. J., INOUE, T., Liu, W. C., WALLACE, S., and WRIGHT, K. C., Anti. Cancer Drugs, 1996, 7(2), 220–227.
  • Permeability control of active agent from polymeric microcapsules by coating of gelatin/ gum arabic membrane. YOSHIZAWA, H., UEMURA, Y., thorn, K., HANO, T., KAWANO, Y., and HATATE, Y., y. Chem. Eng. Ypn., 1996, 29(2), 379–381.
  • pH-sensitive chitosan/gelatin hybrid polymer network microspheres for delivery of cime-tidine. YAO, K. D., Xu, M. X., YIN, Y. J., ZHAO, J. Y., and CHEN, X. L., Polym. Int., 1996, 39 (4), 333–337.
  • pH-sensitive, cationic liposomes: a new synthetic virus-like vector. BUDKER, V., GUREVICH, V., HAGSTROM, J. E., BORTZOV, F., and WOLFF, J. A., Nat. Biotechnol., 1996, 14 (6), 760–764.
  • Pharmaceutical evaluation of gelatin microspheres crosslinked with dl-glyceraldehyde. Determinations of residuals of the preparation procedure. GRI FFINI, A., VANDEL LI, M. A., SEGHIZZI, R., Mucci, A., and PIFFERI, G., Pharm. Pharmacol. Lett., 1996, 6(1), 16–18.
  • Pharmacokinetic characteristics of two types of liposomal FK 506. YAGURA, K. NAKAJIMA, Y., Ko, S., KANEHIRO, H., and NAKANO, H., Transplant Proc., 1996, 28 (3), 1390–1391.
  • Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents and clinical trials. HAGIWARA, A., ITOH, M., TAKAHASHI, T., SHIMOTSUNIA, M., SAKAKURA, C., SHIRASU, M., OSAKI, K., TSUJINIOTO, H., OHGAKI, M., ET AL., Proc. Int. Cancer Congr., Free Pap. Posters, (16th) 1994, pp. 2793–2797.
  • Phospholipids-liposomes-nanoemulsions. I. Production, legislation, and properties. GAREI, J., and RADOS, S. B., Cosmet. Toiletries, (Ed hal), 1996, 17 (2), 80–81. 83–86.
  • Physical stability of teniposide in bile salt-egg phosphatidylcholine mixed micelles and liposomes. SON, K., ALKAN, 0. H., PDA y. Phartn. Sci. Technol., 1996, 50 (2), 89–93.
  • PLA2 promotes fusion between PMN-specific granules and complex liposomes. BLACKWOOD, R. A., TRANSUE, A. T., HARSH, D. M., BROWER, R. C., ZACHAREK, S. J., SMOLEN, J. E., and HESSLER, R. J., y. Leukoc. Biol. 1996, 59 (5), 663–670.
  • Placental transfer of valproic acid after liposome encapsulation during in vitro human placenta perfusion. BARZAGO, M. M., BORTOLOTTI, A., STELLARI, F. F., DIONIEDE, L., ALGER, M., EFRATI, S., SALMONA, M., and BONATI, M., y. Pharmacol. Exp. Ther., 1996, 277(1), 79–86.
  • Plasma protein adsorption patterns on liposomes: establishment of analytical procedure. DIEDERICIIS, J. E., Electrophoresis, 1996, 17 (3), 607–611.
  • Plasmodium falciparum: the adherence of erythrocytes infected with human malaria can be mimicked using pfalhesin-coated microspheres. GUTFIRIE, N., BIRD, D. M., CRANDALL, I., and SHERMAN, I. W., Cell Adhes. Commun., 1995, 3(5), 407–417.
  • Plurilamellar multivesicular liposomes. Ethodology, and cosmetic applications. GARCIA, J. M., NIETO, A., MARTI, E., DEL Pozo, A., DELGADO, R., and PONS, F., SOFWY., 1996, 122 (4), 206, 208–209.
  • Poly(epsilon-caprolactone) microspheres as a vaccine carrier. JAMEELA, S. R., SUMA, N., 1VlissA, A., RAGHUVANSHI, R., GANGA, S., and JAYAKRISHNAN, A., Curt. Sc., 1996, 70 (7), 669–671.
  • Poly(DL-lactic acid) microspheres incorporating histological dyes for intra-pulmonary histo-pathological investigations. ARMSTRONG, D. J., ELLIOTT, P. N. C., FORD, J. L., GADSDON, D., MCCARTHY, G. P., ROSTRON, C., and WORSLEY, M. D., J. Pharm. Pharmacol., 1996, 48 (3), 258–262.
  • Poly(ethylene glycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. HOLLAND, J. W., Hui, C., CuLt.is, P. R., and MADDEN, T. D., Biochemistry, 1996, 35 (8), 2618–2624.
  • Poly(glycolide-co-DL-lactide) microsphere-entrapped tetanus toxoid: safety evaluation in Wistar rats. CHAUDHURY, M. R., SHARMA, K., and GIRI, D. K., Hum. Exp. Toxicol., 1996, 15 (3), 205–207.
  • Poly(L, L-lactide) microspheres by ring-opening polymerization. SOSNOWSK1, S., GADZINOWSKI, M., and SLonIKOWSKI, S., Macromolecules, 1996, 29 (13), 4556–4564.
  • Polylysine enhances cationic liposome-mediated transfection of the hepatoblastoma cell line Hep G2. MACK, K. D., WALZEM, R. L., LEHMANN, B. K., POWELL, J. S., and ZELDIS, J. B., Biotechnol. Appl. Biochem., 1996, 23 (3), 217–220.
  • Pre-clinical development of liposomal all-trans retinoic acid. MEFITA, K., LOPEZ, B. G., GINSBERG, C., DRACH, J., ANDREEFF, M., and ESTEY, E., Proc. Int. Cancer Congr., Free Pap Posters, 16th, 1994, 651–655.
  • Preparation and evaluation of controlled-release microspheres containing nicardipine hydrochloride. YUKSEL, N., and BAYKARA, T., Int. J. Pharm. Adv., 1996, 1 (4), 398–407.
  • Preparation of polymer-rnicroencapsulated calcium carbonate by suspension polymer-ization. KIM, D. K., Kim, K. T., and CHANG, Y. W., Korea Polym. y., 1995, 3 (2), 82–85.
  • Preparation of biodegradable microcapsules of zidovudine using solvent evaporation: effect of the modification of aqueous phase. MANDAL, T. K., and TENJARLA, S., Mt. J. Pharm., 1996, 137 (2), 187–197.
  • Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. BERTHOLD, A., CREMER, K., and KREUTER, J., Y. Controlled Release, 1996, 39 (1), 17–25.
  • Preparation and physical properties of ferromagnetic mitomycin C bearing microspheres. JIAO, Y., LIN, S., ZHANG, X., GUO, Y., Xu, J., Li, L., and GE, X., Zhongguo Yaoxue Zazhi, 1996, 31 (1), 27–29.
  • Preparation and characterization of a complex microencapsulated diet for striped bass Morone saxatilis larvae. OZKIZILCIK, S., and CHU, F. L. E.,.7. Microencapsulation, 1996, 13 (3), 331–343.
  • Preparation of '251-F (ab')2-DNR-liposomes and radioimmunoassay of their specific con-jugating ability. Liu, J., CHEN, Z., LIU, H., FAN, Q., SHEN, D., and Li, S., Zhongguo Yixue Kexueyuan Xuebao, 1995, 17 (5), 383–386.
  • Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique. MANDAL, T. K., LOPEZ, A. A., ONYEBUEKE, E., and SHEKLETON, M., MiCrOenCapSU/atiOn, 1996, 13 (3), 257–267.
  • Preparation of monodisperse microspheres using the Shirasu porous glass emulsification technique. Omi, S., Colloids Surf., A, 1996, 109, 97–107.
  • Preparation of sodium alginate microspheres containing hydrophilic beta-lactam antibiotics. CHUN, K. H., KWON, I. C., KIM, Y. H., LA, S. B., SOFIN, Y. T., and JEONG, S. Y., Arch. Pharmacal. Res., 1996, 19(2), 106–111.
  • Preparation of titanium hexacyanoferrate microspheres (diameter 70 pm) by water extraction variant of sol-gel process and its application to sorption of 137Cs from nuclear reactor cooling water. DEPTULA, A., CHMIELEWSKI, A. G., LADA, W., and OLCZAK, T., Mater. Res. Soc. Symp. Proc., 1996, 412 (Scientific Basis for Nuclear Waste Management XIX), 653–658.
  • Preparation of magnetic albumin microspheres carrying adriamycin and its localization in rabbit lung. CHENG, D., and TANG, M., Disi Yunyi Daxue Xuebao, 1996, 17(1), 39–41.
  • Preparation of microcapsules containing water-soluble macromolecular extractants. ASAKI, M., F1'KuniOTO, 'F., and WATARAI, H., Proc. Symp. Solvent. Extr., 1995, 23–24.
  • Preparation of superoxide dismutase entrapped in ceramide-containing liposomes for oral administration. REGNAULT, C., BENOIST, C., FESSI, H., ROCH, A. M., POSTAIRE, E., and HAZEBROVCQ. G., Int. y. Pharm., 1996, 132 (1,2), 263–266.
  • Preparation and evaluation of phenyltoloxamine citrate microspheres. SAMY, E. M., MOHAMED, F. A., ALI, A. S., ANWAR, M. M., and ABOUTALEB, A. E., Bull. Pharm. Sci. Assiut. Univ., 1995, 18 (2), 125–134.
  • Preparation of oral berberine bisulfate liposomes. XUE, Y., WENG, G., HE, J., and Xu, B., Zhongguo Zhongyao Zazhi, 1995, 20(12), 730–731.
  • Preparation, properties and the effects of amikacin, netilmicin and tobramycin in free and liposomal formulations on Gram-negative and Gram-positive bacteria. OMRI, A., and RAVAOARINORO, M., Int. y. Antimicrob. Agents, 1996, 7 (1), 9–14.
  • Probe technique for measuring the thermal conductivity of hollow glass microspheres. Luo, W., and Yu, X., Proc. Beijing Int. Symp. Pyrotech. Explos, 3rd, China Ordance Society, Beijing, Peop. Rep. China, 1995, 474–478.
  • Prolonged immune response evoked by a single subcutaneous injection of microcapsules having a monophasic antigen release. SAH, H., and CHIEN, Y. W.,.7. Pharm. Pharmacol., 1996, 48 (1), 32–36.
  • Protective effect of amphiphilic ammonium salts on the oxidation of lecithin liposomes. GABRIELSKA, J., KLESZCYNSKA, H., and PRZESTALKI, S., Z. Natutforsch., C: Biosci., 1995, 50 (11/12), 840–844.
  • Purification of beta-adrenergic receptors from Beijing duck erythrocyte plasma membranes and their reconstitution with Gs and adenylate cyclase on asolectin liposomes. FAN, G., YANG, X., and HUANG, Y., Chin. Sci. Bull., 1995, 40 (24), 2075–2080.
  • Rapid separation of peptides and proteins on 2 pm porous microspherical reversed-phase silica material. MORIYAMA, H., ANEGAYAMA, M., and KATO, Y., Chromatogr, A., 1996, 729 (1 + 2), 81–85.
  • Receptor-mediated endocytosis of poly(acrylic acid)-conjugated liposomes by macrophages. FUJIWARA, M., BALDESCHWIELER, J. D., and GRUBBS, R. H., Biochim. Biophys. Acta, 1996, 1278 (1), 59–67.
  • Recombinant human tumor necrosis factor-alpha covalently conjugated to long-circulating liposomes. Mom, A., DUDA, E., and HUANG, L., Int. y. Pharm., 1996, 131 (1), 57–66.
  • Reconstitution of the steroidogenic pathway from cholesterol to aldosterone in liposome membranes. KOMINAMI, S., NISHIDA, N., and TAKEMORI, S., Biochim. Biophys. Acta, 1996, 1301 (3), 199–206.
  • Regulation of neutral cholesterol esterase activity by phospholipids containing negative charges in substrate liposome. Ism I, I., ONOZAKI, R., TAICAHASH I, E., TAKAHASHI, S., FUJI 0, N., HARADA, T., MORISAKI, N., SHIRAI, K., SAITO, Y., and HIROSE, S.,.7. Lipid. Res., 1995, 36 (11), 2303–2310.
  • Release kinetics of liposome-encapsulated ganciclovir after intravitreal injection in rabbits. LE BOURLAIS, C., CHEVANNE, F., ROPERT, P., BRETAGNE, G., ACAR, L., ZIA, H., SADO, P. A., NEEDHAM, T., and LEVERGE, R.,.7. Microencapsulation, 1996, 13 (4), 473–480.
  • Research of cephradine-ethylcellulose microcapsules. TANG, H., YANG, W., ZHAO, G., and Zou, L., Zhongguo Yiyao Gongye Zazhi, 1996, 27 (1), 11–14.
  • Revelation of chemical functions of powders. Microencapsulation and ultrafine particles. TSUBOTA, S., HAHATA, M., and NAKAHARA, Y., Kagaku Sochi, 1996, (5), 66–70.
  • Reversed-phase liquid chromatography on a microspherical carbon column at high temper-ature. YAMAKI, S., 'son, T., OKUYAMA, T., and SHINODA, T., J. Chromatogr., A, 1996, 728 (1 + 2), 189–194.
  • Scattering studies of poly(urea-urethane) microcapsules in suspension. DOBASHI, T., TAKENAKA, M., YEH, F. J., Wu, G., ICHIKAWA, K., and CHU, B., y. Colloid Interface Sci., 1996, 179 (2), 640–642.
  • Serum independent liposome uptake by mouse liver. Liu, F., and Liu, D., Biochim. Biophys. Acta, 1996, 1278 (1), 5–11.
  • Sialyl Lewis x liposomes as a multivalent ligand and inhibitor of E-selectin-mediated cellular adhesion. DEFREES, S. A., PHILLIPS, L., ZALIPSKY, S., and Guo, L., Y. Am. Chem. Soc., 1996, 118 (26), 6101–6104.
  • Simplex lattice design for the optimization of the microencapsulation of water soluble drug using poly(lactic acid) and poly(lactide co-glycolide) copolymer. ELKHESHEN, S., Y. Microencapsulation, 1996, 13 (4), 447–462.
  • Simulation of light attenuation within fluorescent microspheres used for liquid fraction separation recorded by a CSLM. LILJEBORG, A., Proc. SPIE-Int. Soc. opt. Eng., 1996, 2655 (Three-dimensional microscopy: image acquisition and processing III), 11–17.
  • Site-specific drug targeting with fluorouracil microspheres. FRUITWALA, M. A., and SANGHAVI, N. M., Drug Delivery, 1996, 3 (1), 5–8.
  • Solvent and plasticizer influences on ethyl cellulose-microcapsules. Num), M. E., BALLESTEROS, M. P., and FRUTOS, P., y. Microencapsulation, 1996, 13 (3), 307–318.
  • Some chosen concentrations of capsule case components and their effect on vitamin A microcapsule obtaining and properties. DOLINSKA, B., and RYSZKA, F., Acta Pharm. (Zagreb), 1996, 46 (1), 89–92.
  • Spiral growth mechanisms in sol-gel YBa2Cu307-delta. microspheres. NIARELLA, M., IVIouNas, B., BURTET, F. B., MeaecALLI, L., and GERONTOPOULOS, P., Adv. Sci. Technol., 1995, 8 (Superconductivity and superconducting materials technologies), 373–380.
  • Spontaneous emission rate and level shift of an atom inside a dielectric microsphere. KLIMOV, V. V., DUCLOY, M., and LETOKHOV, V. S., .y. Mod. opt., 1996, 43 (3), 549–563.
  • Stability and uses of liposomes. RIAZ, M., Pak. y. Pharm. Sc., 1995, 8(2), 69–79.
  • Stabilization of liposomes for controlled release. MAKIN°, K., Fragrance, y., 1996, (4), 85-93. Sterically stabilized liposomes: pharmaceutical benefits from surface bound PEG coating. WOODLE, M. C., Polym. Mater. Sci. Eng., 1993, 69, 517–518.
  • Studies on microporous membrane for microencapsulated pancrease. SUN, H., SONG, C., SHI, R., Hu, G., and ZHANG, Y., Zhongguo Shengsvu Yixue Gongcheng Xuebao, 1995, 14(4), 289–291. 323.
  • Study of insulin containing liposomes from equimolar mixture of dipalmitoylphosphati-dylcholine and dipalmitoylphosphatidylethanol as an oral dosage form. AKHREM, A. A., VLASOV, A. P., VOROBYOV, M. S., ZABOROVSKAYA, Z. V., KISEL, M. A., KHOLODOVA, Y., and TSYBOVSKY, I. S., Khim. Farm. Zh., 1994, 28 (10), 34–37.
  • Study of liposomal drug delivery systems. 3 Dynamic in-vitro release of steroids from multilamellar liposomes. LOPES DE, M. D. E., and VARGFIA, B. E. I., Colloids Surf., B, 1996, 6 (4/5), 269–277.
  • Study on emulsion non-solvent addition method of compound polymer microcapsules. DONG, Q., Guo, Q., and TANG, W Gaofenzi Cailiao Kexue Yu Gongcheng, 1996, 12 (3), 137–140.
  • Study on slow-release characteristics of microcapsules with emulsion non-solvent addition method. CHEN, G., DONG, Q., and Guo, Q., Gaofenzi Cailiao Kexue Yu Gongcheng, 1996, 12 (2), 128–131.
  • Surface modification of continuously extruded contrast-carrying liposomes: effect on their physical properties. SCHNEIDER, T., SACHSE, A., LEIKE, J., ROESSLING, G., SCHMIDTGEN, M., DRECHSLER, M., and BRANDL, M., Int.J. Pharm., 1996, 132 (1,2), 9–21.
  • Surrogate cells or Trojan horses. The discovery of liposomes. BANGHAM, A. D., Bioessays, 1995, 17 (12), 1081–1088.
  • Synthesis of liposomal phospholipid-(N4-palmitoy1-1-beta-D-arabinofuranosylcytosine) con-jugates and evaluation of their cytostatic activity against L1210 murine leukemia. Scuorr, H., and SCHWENDENER, R. A., Liebigs. Ann. 1996, (3), 365–369.
  • Synthesis and liposome-formation of a lipid bearing cell-adhesion peptide sequence. Hof°, H., KOJIMA, T., YAMAUCHI, K., and KINOSHITA, M., Pept. Chem., 1996, 33rd, 377–380.
  • Synthesis of diacetylenic lipids and studies on the preparation and stability of polymerized liposomes. Yu, K., SUN, Y ZHANG, B., and ZHOU, X., Gaodeng Xuexiao Huaxue Xuebao, 1996, 17 (3), 392–395.
  • Synthesis and evaluation of neoglycolipid for liposome modification. MURAHASHI, N., YAMADA, H., WATANABE, H. K., HicAstn, K., MIYOSHI, S., YAMAUCHI, H., and NAKABAYASHI, S., Drug Delivery Syst., 1996, 11(2), 91–97.
  • Technological innovation in wool dyeing with azo disperse dyes via liposomes. DE LA MAZA, A., PARRA, J. L., MANICH, A. M., and CODERCH, L., Bol INTEXTER Inst. Invest. Text coop. Ind., 1995, 108, 37–44.
  • Temperature-responsive polymer microspheres prepared with a macroinitiator. KITANO, H., and KAWABATA, J Macromol. Chem. Phys., 1996, 197 (5), 1721–1729.
  • The importance of standardization of carboxymethylchitin concentration by the dye-binding capacity of Alcian Blue before adsorption on liposomes. MOBED, M., ENG, M., and CHANG, T. M. S., Anil. Cells, Blood Substitutes, Immobilization Biotechnol., 1996, 24 (2), 107–120.
  • The synthesis of uniform polymer functional microspheres for immunoassays. PROKOPOV, N. I., GRITSKOVA, I. A., CHERKASOV, V. R., and CHALYKH, A. E., Usp Khim, 1996, 65 (2), 178–192.
  • The effect of free and liposome-entrapped praziquantel on serum activity of aminotrans-ferases in mice infected with Mesocestoides corti tetrahyridia. VELEBNY, S., and HRCKOVA, G., Helminthologia, 1995, 32 (4), 193–199.
  • The effect of microfluidization of protein-coated liposomes on protein distribution on the surface of generated small vesciles. SKALKO, N., BOUWSTRA, J., SPIES, F., and GREGORIADIS, G., Biochim. Biophys. Acta, 1996, 1301 (3), 249–254.
  • The in vivo characteristics of adriamycin after embolization of the hepatic artery with adriamycin-carrying liposomes in dogs. PIAO, X., WANG, Z., Wu, D., ZHANG, G., Xu, S., and WEN, A., Disi junyi Daxue Xuebao, 1996, 17(1), 42–45.
  • The preparation and evaluation of salbutamol sulfate containing poly (lactic acid-co-glycolic acid) microspheres with factorial design-based studies. CELEBI, N., ERDEN, N., and TUERKYILMAZ, A., Int. .y. Pharm., 1996, 136 (1,2), 89–100.
  • The pro-liposome method: a practical approach to the problem of the preparation and utilization of liposomes suitable for topical applications. PATRICK, W. W., Peaaerr, S., GoLoma, M., ARNACD, J. P., and Micitez, M., Phospholipids: Charact, Metab, Novel Biol. Appl., Proc. Int. Colloq., 6th, 1995, pp. 181–188. utilization of liposomes suitable for topical applications. PATRICK, W. W., PERRE-rr, S., GOLDING, M., ARNAUD, J. P., and MICHEZ, M., Phospholipids: Charact, Metab, Novel Biol. Appl., Proc. Int. Colloq., 6th, 1995, pp. 181–188.
  • The release of clindamycin phosphate from a suspension of different types of liposomes and selected topical dosages forms. ARNARDOTTIR, H. B., SvEiNssoN, S. J., and KRISTMUNDSDOTrIR, T., Int. J. Pharm., 1996, 134 (1,2), 71–77.
  • The structure of the main barrier of the skin, the stratum corneum: changes in this structure after incubation with alkyl-azones or liposomes. BOUWSTRA, J. A., GOORIS, G. S., SALOMONS DE, V. M. A., and VAN DEN BERGH, B. A. I., Phospholipids: Charact, Metab, Novel. Biol. Appl., Proc. Int. Colloq., 6th, 1995, pp. 159–180.
  • The use of the Rank electrode for the detection of the activity of liposomally encapsulated enzymes. KASZUBA, M., TAYLOR, M. A., and JONES, M. N., Biochem. Soc. Tran., 1995, 23 (4), 568S.
  • The effect of cornea proteoglycans on liposome peroxidation. ALBERTINI, R., RINDI, S., PASSI, A., BARDONI, A., SALVINI, R., PALLAVICINI, G., and DE Luca, G., Arch. Biochem. Biophys., 1996, 327 (2), 209–214.
  • The influence of Pseudomonas aeruginosa on liposomes. ANTOS, M., TRAFNY, E. A., and GRZYBOWSKI, J., Folia Microbiol (Prague), 1996, 41(1), 29–32.
  • The rheological properties of glass microsphere filled polypropylene. LIAO, J., ZHENG, H., and Hu, S., Hecheng Shuzhi ji Suliao, 1996, 13 (1), 35–38.
  • Thermochemotherapy of murine melanomas using heat sensitive liposomes containing melphalan and hyperthermia. CHELVI, T., JAIN, S., and RA LHAN, R., Proc. In:. Cancer Congr., Free Pap. Posters, 16th, 1994, pp. 829–833.
  • Toughening of epoxy resin with microspheres. JIN, S., FENG, X., PANG, J., Hut, X., Li, Y., and Yu, u., y. Mater. Sci. Technol. (Shenyang, People's Repub. China), 1996, 12(1), 46-50.Trypsin purification by affinity precipitation with polymerized liposome as ligand carrier. DONG, ONG., SUN, Y., Yu, K., and JIN, X., Huagong Xuebao (Chin. Ed.), 1996, 47 (2), 222-227. Tumor selective gene transduction by intraperitoneal administration of cationic liposomes. NamiKI, amiKI., TAKAHASHI, T., and OHNO, T., jikeikai Med. y., 1996, 43 (1), 9–21.
  • Two- and three-dimensional crystallization of polymeric microspheres by micromolding in capillaries. KIM, E., XIA, Y., and WHITESIDE, G. M., Adv. Mater. (Weinheim, Ger), 1996, 8 (3), 245–247.
  • Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies. TIAN, J. H., XLI, B. X., ZHANG, J. M., DONG, B. W., LIANG, P., and WANG, X. D., J. Nucl. Med., 1996, 37 (6), 958–963.
  • Use of dual-labeled microcapsules to discern the physiological fates of assimilated carbon-hydrate, protein carbon, and protein nitrogen in suspension-feeding organisms. KREEGER, D. A., HAWKINS, A. J. S., and BAYNE, B. L., Limnol. Oceanogr., 1996, 41 (2), 208–215.
  • Validation of a subendocardial ischemic sheep model by intracoronary fluorescent micro-spheres. Li, D. S., YONG, A. C., and KILPATRICK, D., Clin. Exp. Pharmacol Physiol., 1996, 23 (2), 111–118.
  • X-ray diffraction analysis of cytochrome P450 2114 reconstituted into liposomes. MILLER, J. P., HERBETTE, L. G., and WHITE, R. E., Biochemistry. 1996, 35 (5), 1466–1474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.